// App-Quantinova.ai

e20053 : Association with consolidation chemotherapy after concurrent chemoradiotherapyfollowed by surgery and the disease free survival in patients with stage III non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Yuka Kato

Principal Investigators

  • Katsuyuki Hotta

  • Go Makimoto

  • Takashi Ninomiya

  • Toshio Kubo

  • Kadoaki Ohashi

  • Eiki Ichihara

  • Akiko Sato

  • Masahiro Tabata

  • Susumu Kanazawa

  • Shinichi Toyooka

  • Mitsune Tanimoto

  • Katsuyuki Kiura

Medical Centers

  • Center for Innovative Clinical medicine, Okayama Unversity Hospital, Okayama, Japan

  • Center for Innovative Clinical medicine, Okayama Unversity Hospital, Okayama, Japan

  • Department of Respiratory Medicine and Allergy, Okayama University Hospital, Okayama, Japan

  • Okayama University Hospital, Okayama, Japan

  • Department of Respiratory Medicine and Allergy, Okayama University Hospital, Okayama, Japan

  • Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Hospital, Okayama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved